In the process of replicating themselves, cells have another choice: do they want to make an identical copy and be left with two cells? Or do they want to make four “half-copies”, in preparation for ...

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript November 19, 2025 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $-0.16463 EPS, expectations were $-0.11.

ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...

ProPhase Labs has put a diagnostic-testing unit into bankruptcy, a move it has been planning as a way to collect on millions of dollars in accounts receivables from its days processing Covid-19 tests ...

Welcome to today's presentation. My name is Noella Alexander-Young, virtual event moderator here at Renmark Financial Communications. On behalf of our team, we want to thank everyone for joining us ...

ProPhase Labs Inc (NASDAQ:PRPH) is pursuing a $50 million cash recovery from COVID-19 receivables through Crown Medical Collections, which could significantly boost the company's market cap. The ...

Hello, and good morning everyone. Welcome to today's presentation. My name is NoellaAlexander-Young, Virtual Event Moderator here at Renmark Financial Communications. On behalf of our team, we want to ...

ProPhase Labs Inc (NASDAQ:PRPH) has made significant cost reductions, including reducing headcount from 96 to 25 employees, which will lower overhead expenses. The company has a promising esophageal ...